A Japanese Nationwide Survey on the FDG-PET Scans for Dementia: Analysis on the Predicted Costs and Benefits of FDG-PET for Early Diagnosis of Alzheimer
Michio Senda, Kanji TORIZUKA, Hidehiko Okazawa(University of Fukui), Yasuomi Ouchi(Hamamatsu Photonics (Japan)), Kenji Ishii(National Institutes for Quantum Science and Technology), Shunya Ikeda(Hiroshima University), Kimiichi Uno(Nishida Hospital), Noriyuki Kato(Mie University), Kengo Ito(National Center for Geriatrics and Gerontology), Kohei Hayashida, Naohiko Oku, Yasuo Kuwabara(Fukuoka University Hospital), Kazunari ISHII, K Ishizu, Seiji Nasu, Toshihiko Nakashima, Joji Kawabe
Cited by 3
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
What has made the population of Japan healthy?
|The Lancet|2011|677
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
|Alzheimer s & Dementia|2015|605